Familial macrothrombocytopenia due to a double mutation in cis in the alpha-actinin 1 gene (ACTN1), previously considered to be chronic immune thrombocytopenic purpura

Danny Kanhai, René Mulder, Hans Kristian Ploos van Amstel, Roger Schutgens, Michael Lukens, Rienk Y.J. Tamminga*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

Congenital thrombocytopenia can easily be misdiagnosed as immune thrombocytopenic purpura, as is illustrated by this case of a woman and her two children. Doubts arose when steroid/IVIG therapy failed in the mother and the thrombocytopenia in the children persisted. By means of next-generation sequencing, two missense variants in cis in the ACTN1 gene of the affected family members were identified, both of unknown significance. We conclude, after further analysis of these mutations with, among others, in silico prediction tools, that the thrombocytopenia has a genetic cause, in particular the ACTN1 mutations, and is not immune mediated.

Original languageEnglish
Article numbere27418
JournalPediatric Blood and Cancer
Volume65
Issue number12
DOIs
Publication statusPublished - 1 Dec 2018

Keywords

  • actinin 1
  • ACTN1
  • congenital macrothrombocytopenia
  • ITP
  • next-generation sequencing

Fingerprint

Dive into the research topics of 'Familial macrothrombocytopenia due to a double mutation in cis in the alpha-actinin 1 gene (ACTN1), previously considered to be chronic immune thrombocytopenic purpura'. Together they form a unique fingerprint.

Cite this